Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Planetarium study: Rabeprazole for prevention of recurrent aspirin-induced peptic ulcers
jRCT2080221499Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rabeprazole in gastric ulcer, duodenal ulcer and Peptic ulcer disease (PUD) (3 arms), sponsored by Eisai Co., Ltd.
02
Drugs
rabeprazole
03
Conditions
gastric ulcerduodenal ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080221499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221499.